XML 43 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Significant Accounting Policies (Tables)
12 Months Ended
Jan. 31, 2016
Accounting Policies [Abstract]  
Schedule of Bad Debt Expense
Bad debt expense for fiscal years 2015 and 2014 was as follows:
 
2015
 
2014
Bad debt expense
$
124,000

 
$
441,000

Property, Plant and Equipment
Property and equipment are stated at cost. Depreciation is computed using the straight-line method, over the estimated useful lives of the related assets. Estimated useful lives are as follows:
Computer equipment and software
3-4 years
Office equipment
5 years
Office furniture and fixtures
7 years
Leasehold improvements
Term of lease
Fair Value of Liabilities on a Recurring Basis
The table below provides information on our liabilities that are measured at fair value on a recurring basis:
 
Total Fair Value
 
Quoted Prices in Active Markets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
At January 31, 2016
 
 
 
 
 
 
 
Warrants liability (1)
$
205,000

 
$

 
$

 
$
205,000

Royalty liability (2)
2,292,000

 

 

 
2,292,000

 
 
 
 
 
 
 
 
At January 31, 2015
 
 
 
 
 
 
 
Warrants liability (3)
$
1,834,000

 
$

 
$

 
$
1,834,000

Royalty liability (2)
2,386,000

 

 

 
2,386,000

 _______________
(1)
The initial fair value of warrants liability was determined by management with the assistance of an independent third-party valuation specialist, and by management thereafter. See Note 4 - Derivative Liabilities, and Note 14 - Private Placement Investment for further details. Changes in fair value of the warrants are recognized within miscellaneous income in the consolidated statements of operations.
(2)
The initial fair value of royalty liability was determined by management with the assistance of an independent third-party valuation specialist, and by management thereafter. The fair value of the royalty liability is determined based on the probability-weighted revenue scenarios for the Looking Glass® Clinical Analytics solution licensed from Montefiore Medical Center (discussed in Note 3 - Acquisitions). Fair value adjustments are included within miscellaneous income in the consolidated statements of operations.
(3)
The fair value of warrants liability as of January 31, 2015 was determined by management with the assistance of an independent third-party valuation specialist using Monte-Carlo simulations. See Note 4 - Derivative Liabilities for further details.
Schedule of Capitalized Software Development Costs
Amortization expense on all internally developed software was $3,073,000 and $3,678,000 in fiscal 2015 and 2014, respectively, and was included in the consolidated statements of operations as follows:
 
Fiscal Year
Amortization expense on internally developed software included in:
2015
 
2014
Cost of systems sales
$
2,747,000

 
$
3,352,000

Cost of software as a service
326,000

 
326,000

Total amortization expense on internally developed software
$
3,073,000

 
$
3,678,000

Schedule of Earnings Per Share, Basic and Diluted
The following is the calculation of the basic and diluted net loss per share of common stock:
 
Fiscal Year
 
2015
 
2014
Net loss
$
(4,290,115
)
 
$
(12,011,457
)
Less: deemed dividends on Series A Preferred Stock
(1,336,072
)
 
(1,038,310
)
Net loss attributable to common shareholders
$
(5,626,187
)
 
$
(13,049,767
)
Weighted average shares outstanding used in basic per common share computations
18,689,854

 
18,261,800

Stock options and restricted stock

 

Number of average shares used in diluted per common share computation
18,689,854

 
18,261,800

Basic net loss per share of common stock
$
(0.30
)
 
$
(0.71
)
Diluted net loss per share of common stock
$
(0.30
)
 
$
(0.71
)